Invited at baseline | Baseline responders | At least 1 monthly response | At least 2 monthly responses* | At least 5 monthly responses† | |
n | 2858 | 1696 | 871 | 777 | 661 |
Condition group | |||||
IHD | 2526 (88) | 1501 (89) | 783 (90) | 701 (90) | 603 (91) |
HF | 332 (12) | 195 (11) | 88 (10) | 76 (10) | 58 (9) |
Age | |||||
<60 | 401 (14) | 172 (10) | 103 (12) | 89 (11) | 75 (11) |
60–69 | 782 (27) | 463 (27) | 265 (30) | 241 (31) | 201 (30) |
70–79 | 987 (35) | 652 (38) | 339 (39) | 304 (39) | 274 (41) |
80+ | 688 (24) | 409 (24) | 164 (19) | 143 (18) | 111 (17) |
Gender | |||||
Male | 1712 (60) | 1059 (62) | 574 (66) | 514 (66) | 447 (68) |
Female | 1146 (40) | 637 (38) | 297 (34) | 263 (34) | 214 (32) |
Baseline chest pain | N/A | 689 (44) | 359 (44) | 318 (43) | 266 (42) |
Baseline SoB | N/A | 942 (58) | 495 (58) | 430 (57) | 354 (54) |
*Population for sensitivity analysis.
†Population for main analysis.
HF, heart failure; IHD, ischaemic heart disease; SoB, shortness of breath.